Why Unum Therapeutics Is Trading Higher Today

Unum Therapeutics UMRX shares are trading higher on Friday after the company's 13D filing from Fairmount Funds disclosed a 19.99% active stake.

Unum Therapeutics Inc is a U.S.-based clinical-stage biopharmaceutical company. It is focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient's immune system to cure cancer.

Unum Therapeutics shares were trading up 7.81% at $3.24 at the time of publication on Friday. The stock has a 52-week high of $3.72 and a 52-week low of 30 cents.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny Stockswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!